Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using shock wave therapy to treat jaw pain from muscle disorders

Official title: Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin: a Randomized, Double-blind, Controlled Clinical Trial

Run by University of Sao Paulo General Hospital · NCT05907239 · Data updated 2026-11-12

This study is testing if shock wave therapy can help people with jaw pain from muscle disorders feel better and improve their daily life.

More Temporomandibular Joint Disorders trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Sao Paulo General Hospital
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedApril 20, 2023
Main results expectedNovember 3, 2027
Study endsJune 25, 2029
Registry record updatedMarch 25, 2026
Trial IDNCT05907239 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults experiencing moderate to severe myofascial pain in the temporomandibular region for at least three months.

Probably not a fit

Patients with coagulopathy, active infections, or those who have undergone recent surgical treatments for TMD may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of extracorporeal shock wave therapy (ESWT) in alleviating pain associated with temporomandibular disorders (TMD) of muscular origin. The study involves a double-blind randomized controlled design with 100 participants, divided into a treatment group receiving ESWT and a control group receiving a placebo treatment. Pain levels, range of motion, inflammation, and quality of life will be assessed at multiple time points throughout the study. The goal is to determine if ESWT can significantly improve symptoms and overall function in patients suffering from TMD.

Why it matters

Potential benefit: If successful, this therapy could provide a non-invasive treatment option for patients suffering from chronic jaw pain.

How similar studies have gone: Previous studies have shown positive outcomes with shock wave therapy for musculoskeletal disorders, suggesting potential for success in this application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pain in the temporomandibular region;
* Myofascial pain diagnosed with or without limitation of mouth opening based on the Diagnostic Criteria for TMD (DC/TMD);
* Myofascial pain associated or not with joint abnormalities;
* Presence of moderate to severe pain: Visual Analogue Scale (VAS) \>4;
* Duration of TMD pain (temporomandibular musculoskeletal) ≥3 months;
* Written granting of the informed consent form to participate in the study

Exclusion Criteria:

* Abnormality in blood clotting (coagulopathy) or using some type of anticoagulant;
* Primary malignant disease (tumors) in the treatment area;
* Acute infection of soft tissue or bone;
* Systemic infections;
* Epilepsy;
* Infiltration of corticosteroids at the application site in the last 6 weeks;
* Patient at high risk of some type of anesthesia or analgesia when it eventually has to be used;
* Polyarthritis;
* Polytrauma Local joint infections;
* Previous temporomandibular surgical treatments that compromise mastication;
* Treatment by physiotherapy, acupuncture before 3 months of performing the procedures
* Depression or other mental disorders;
* Clinical diagnosis of associated fibromyalgia;
* Associated systemic inflammatory rheumatic diseases;
* Widespread pain or pain elsewhere that predominates and overlaps with TMD muscle pain;
* Inability to understand the treatment protocol.

Where it's running

  • University of São Paulo General Hospital
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Wu T Hsing, MD, PhD — University of Sao Paulo
  • Study coordinator: Wu T Hsing, MD, PhD
  • Email: wu@fm.usp.br
  • Phone: +5511981998157

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.